Is pre-treatment MRI minimum apparent diffusion coefficient value a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation?
Pre-treatment ADCmax measured in the primary tumor may be associated with FIGO stage and lymph node status. Pre-treatment ADCmin may be a prognostic factor associated with disease-free survival and disease-specific survival in cervical cancer patients treated with definitive chemoradiation. Prospective validation of these findings is currently ongoing.
The use of electronic decision support prompts in community pharmacy practice can promote the quality use of medicines.